Joint pain improvement in patients on etanercept therapy for moderate to severe psoriasis

被引：0
|
作者：
Tyring, Stephen [1 ]
Kricorian, Gregory [2 ]
Gordon, Kenneth [3 ]
Klekotka, Paul [2 ]
机构：
[1] Univ Texas Houston, Houston, TX USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2011年 / 64卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB158 / AB158
页数：1
相关论文
共 50 条
  • [41] Cost effectiveness - Analysis of Therapy with Ustekinumab versus Etanercept in Patients with moderate to severe Plaque Psoriasis Based on the ACCEPT Study
    Augustin, M.
    Feldman, S.
    Wolbring, F.
    Szapary, P.
    Schenkel, B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 191 - 191
  • [42] Patients with moderate to severe plaque psoriasis show consistently a quick improvement of nail psoriasis
    Schopf, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 193 - 193
  • [43] The effect of exanercept therapy on fatigue in patients with moderate to severe psoriasis
    Cella, D
    Krishnan, R
    Woolley, JM
    Lalla, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P197 - P197
  • [44] QUALITATIVE ASESSMENT OF THE EXPERIENCE OF PAIN IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
    Martin, M. L.
    Gordon, K.
    Bushnell, D. M.
    Pinto, L.
    Viswanathan, H. N.
    VALUE IN HEALTH, 2014, 17 (03) : A288 - A289
  • [45] Cost per responder of apremilast versus etanercept, adalimumab, and ustekinumab in patients with moderate to severe psoriasis
    Feldman, Steven R.
    Tencer, Tom
    Clancy, Zoe
    Zhang, Frank
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB229 - AB229
  • [46] Safety and efficacy of adding topical clobetasol propionate to etanercept in patients with moderate to severe plaque psoriasis
    Lebwohl, Mark G.
    Pariser, David
    Kricorian, Gregory
    Koo, John
    Duffin, Kristina Callis
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB211 - AB211
  • [47] Cost per treated patient for etanercept and ustekinumab in patients treated for moderate to severe plaque psoriasis
    Shah, Neel
    Harrison, David
    Wu, Ning
    Lee, Yuan-Chi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB166 - AB166
  • [48] Etanercept treatment leads to rapid and sustained improvements in the quality of life of patients with moderate to severe psoriasis
    Feldman, S
    Kimball, A
    Woolley, J
    Zitnik, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A55 - A55
  • [49] Etanercept in patients with moderate to severe psoriasis who fail methotrexate: a cost-effectiveness analysis
    Nallamothu, PG
    Nallamothu, BK
    Lim, HW
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A63 - A63
  • [50] Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case Series
    Bourcier, Marc
    Papp, Kim Alexander
    Gulliver, Wayne P.
    Poulin, Yves
    Barber, Kirk
    Poulin-Costello, Melanie
    Shelton, Jennifer
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (06) : 561 - 569
12345